Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.
George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, Maas L, Müller C, Dahmen I, Delhomme TM, Ardin M, Leblay N, Byrnes G, Sun R, De Reynies A, McLeer-Florin A, Bosco G, Malchers F, Menon R, Altmüller J, Becker C, Nürnberg P, Achter V, Lang U, Schneider PM, Bogus M, Soloway MG, Wilkerson MD, Cun Y, McKay JD, Moro-Sibilot D, Brambilla CG, Lantuejoul S, Lemaitre N, Soltermann A, Weder W, Tischler V, Brustugun OT, Lund-Iversen M, Helland Å, Solberg S, Ansén S, Wright G, Solomon B, Roz L, Pastorino U, Petersen I, Clement JH, Sänger J, Wolf J, Vingron M, Zander T, Perner S, Travis WD, Haas SA, Olivier M, Foll M, Büttner R, Hayes DN, Brambilla E, Fernandez-Cuesta L, Thomas RK. George J, et al. Among authors: zander t. Nat Commun. 2018 Mar 13;9(1):1048. doi: 10.1038/s41467-018-03099-x. Nat Commun. 2018. PMID: 29535388 Free PMC article.
Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236.
Staratschek-Jox A, Thomas RK, Zander T, Massoudi N, Kornacker M, Bullerdiek J, Fonatsch C, Diehl V, Wolf J. Staratschek-Jox A, et al. Among authors: zander t. Br J Cancer. 2001 Feb 2;84(3):381-7. doi: 10.1054/bjoc.2000.1593. Br J Cancer. 2001. PMID: 11161403 Free PMC article.
Genetic instability in Hodgkin's lymphoma.
Re D, Zander T, Diehl V, Wolf J. Re D, et al. Among authors: zander t. Ann Oncol. 2002;13 Suppl 1:19-22. doi: 10.1093/annonc/13.s1.19. Ann Oncol. 2002. PMID: 12078897 Free article. Review.
Prognostic factors in Hodgkin's lymphoma.
Zander T, Wiedenmann S, Wolf J. Zander T, et al. Ann Oncol. 2002;13 Suppl 1:67-74. doi: 10.1093/annonc/13.s1.67. Ann Oncol. 2002. PMID: 12078906 Free article. Review.
Epidemiology and etiology of Hodgkin's lymphoma.
Thomas RK, Re D, Zander T, Wolf J, Diehl V. Thomas RK, et al. Among authors: zander t. Ann Oncol. 2002;13 Suppl 4:147-52. doi: 10.1093/annonc/mdf652. Ann Oncol. 2002. PMID: 12401681 Free article. Review. No abstract available.
Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET).
Ullrich RT, Zander T, Neumaier B, Koker M, Shimamura T, Waerzeggers Y, Borgman CL, Tawadros S, Li H, Sos ML, Backes H, Shapiro GI, Wolf J, Jacobs AH, Thomas RK, Winkeler A. Ullrich RT, et al. Among authors: zander t. PLoS One. 2008;3(12):e3908. doi: 10.1371/journal.pone.0003908. Epub 2008 Dec 12. PLoS One. 2008. PMID: 19079597 Free PMC article.
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR.
Sos ML, Koker M, Weir BA, Heynck S, Rabinovsky R, Zander T, Seeger JM, Weiss J, Fischer F, Frommolt P, Michel K, Peifer M, Mermel C, Girard L, Peyton M, Gazdar AF, Minna JD, Garraway LA, Kashkar H, Pao W, Meyerson M, Thomas RK. Sos ML, et al. Among authors: zander t. Cancer Res. 2009 Apr 15;69(8):3256-61. doi: 10.1158/0008-5472.CAN-08-4055. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351834 Free PMC article.
358 results